Usefulness of pre- and post-stent optical frequency domain imaging findings in the prediction of periprocedural cardiac troponin elevation in patients with coronary artery disease.


Journal

Heart and vessels
ISSN: 1615-2573
Titre abrégé: Heart Vessels
Pays: Japan
ID NLM: 8511258

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 14 04 2019
accepted: 20 09 2019
pubmed: 29 9 2019
medline: 16 12 2020
entrez: 29 9 2019
Statut: ppublish

Résumé

Cholesterol crystals (CCs) are frequently found in high-risk plaques, such as thin-capped fibroatheromas. The purpose of this study was to investigate the associations of CCs, plaque morphologies, and post-stent optical frequency domain imaging (OFDI) findings with periprocedural cardiac troponin (cTn) elevation in patients treated with percutaneous coronary intervention (PCI). This study consists of 119 patients with stable coronary artery disease (CAD) with normal cTn levels who underwent OFDI-guided PCI. Periprocedural cTn elevation was defined as an elevation of cTn ≥  × 5 times the upper reference limit after PCI. Pre- and post-stent OFDI findings, including fibrous cap thickness (FCT), presence of CCs, and parameters for lipid and calcification were analyzed. A total of 37 (31%) patients were classified into the periprocedural cTn elevation group. Compared with lesions without CCs, lesions exhibiting CCs had thinner FCT, larger lipid arc, and longer lipid length, and were more likely to have irregular protrusion and in-stent thrombus (all p < 0.05). For pre-stent OFDI features, FCT < 82 µm [odds ratio (OR) 4.11; p = 0.003] and CCs (OR 3.23; p = 0.017) were associated with periprocedural cTn elevation. For post-stent OFDI features, in-stent dissection (OR 3.08; p = 0.035) and in-stent thrombus (OR 7.98; p = 0.002) were independent predictors of cTn elevation. The combination of CCs and FCT < 82 µm showed increased risk of periprocedural cTn elevation (OR 7.22; p = 0.002). OFDI-guided PCI provides unique insight into the mechanism for periprocedural cTn elevation in CAD patients.

Identifiants

pubmed: 31562554
doi: 10.1007/s00380-019-01512-z
pii: 10.1007/s00380-019-01512-z
doi:

Substances chimiques

Biomarkers 0
Troponin I 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

451-462

Références

Arterioscler Thromb Vasc Biol. 2011 Sep;31(9):2007-14
pubmed: 21817102
J Mol Cell Cardiol. 2004 Jul;37(1):23-31
pubmed: 15242732
Atherosclerosis. 2019 Apr;283:79-84
pubmed: 30802681
Eur Heart J Cardiovasc Imaging. 2014 Mar;15(3):284-91
pubmed: 24022065
Am J Cardiol. 2009 Apr 1;103(7):959-68
pubmed: 19327423
Heart Vessels. 2019 Jun;34(6):948-956
pubmed: 30600349
J Am Coll Cardiol. 2006 Mar 7;47(5):981-6
pubmed: 16516081
JACC Cardiovasc Interv. 2011 May;4(5):521-9
pubmed: 21596325
J Am Coll Cardiol. 2017 May 23;69(20):2502-2513
pubmed: 28521888
Circ Cardiovasc Interv. 2012 Feb 1;5(1):89-96, S1-6
pubmed: 22298799
Clin Cardiol. 2005 Sep;28(9):413-20
pubmed: 16250264
JACC Cardiovasc Imaging. 2018 Nov;11(11):1666-1676
pubmed: 29248662
Circulation. 2008 Aug 5;118(6):632-8
pubmed: 18645057
Circulation. 2003 Jul 15;108(2):171-6
pubmed: 12835216
Heart Vessels. 2018 Oct;33(10):1159-1167
pubmed: 29691643
Circulation. 2015 Sep 15;132(11):1020-9
pubmed: 26162917
Eur Heart J. 2011 May;32(10):1251-9
pubmed: 21273202
Heart. 2009 Dec;95(23):1913-9
pubmed: 19671534
Eur Heart J. 2018 Apr 1;39(13):1100-1109
pubmed: 29365133
J Am Coll Cardiol. 2014 Jun 3;63(21):2209-16
pubmed: 24632266
PLoS One. 2010 Jul 23;5(7):e11765
pubmed: 20668705
Am Heart J. 2005 Jul;150(1):102-8
pubmed: 16084155
J Am Coll Cardiol. 2012 May 22;59(21):1881-8
pubmed: 22595407
Eur Heart J. 2008 Jul;29(14):1721-8
pubmed: 18577556
Circ Cardiovasc Interv. 2011 Aug;4(4):378-86
pubmed: 21791670
Circulation. 2009 Nov 3;120(18):1822-36
pubmed: 19884481
J Am Coll Cardiol. 2013 Oct 22;62(17):1563-70
pubmed: 24135581
Nature. 2010 Apr 29;464(7293):1357-61
pubmed: 20428172
J Cardiol. 2017 Jan;69(1):253-259
pubmed: 27156165
Heart Vessels. 2014 Sep;29(5):596-602
pubmed: 24005765
Heart Vessels. 2019 Jul;34(7):1076-1085
pubmed: 30610377
JACC Cardiovasc Interv. 2018 Jul 23;11(14):1313-1321
pubmed: 30025725
Atherosclerosis. 2016 Apr;247:111-7
pubmed: 26897259
JACC Cardiovasc Imaging. 2009 Apr;2(4):458-68
pubmed: 19580729

Auteurs

Kenichiro Otsuka (K)

Department of Cardiovascular Medicine, Ishikiri-Seiki Hospital, 18-28, Yayoi-cho, Higashi-osaka, Japan. otsuka_k@outlook.com.

Kenei Shimada (K)

Department of Cardiovascular Medicine, Kashiba-Seiki Hospital, Kashiba, Japan.

Hirotoshi Ishikawa (H)

Department of Cardiovascular Medicine, Ishikiri-Seiki Hospital, 18-28, Yayoi-cho, Higashi-osaka, Japan.

Haruo Nakamura (H)

Department of Cardiovascular Medicine, Ishikiri-Seiki Hospital, 18-28, Yayoi-cho, Higashi-osaka, Japan.

Hisashi Katayama (H)

Department of Cardiovascular Medicine, Ishikiri-Seiki Hospital, 18-28, Yayoi-cho, Higashi-osaka, Japan.

Hisateru Takeda (H)

Department of Cardiovascular Medicine, Ishikiri-Seiki Hospital, 18-28, Yayoi-cho, Higashi-osaka, Japan.

Kohei Fujimoto (K)

Department of Cardiovascular Medicine, Ishikiri-Seiki Hospital, 18-28, Yayoi-cho, Higashi-osaka, Japan.

Noriaki Kasayuki (N)

Department of Cardiovascular Medicine, Ishikiri-Seiki Hospital, 18-28, Yayoi-cho, Higashi-osaka, Japan.

Minoru Yoshiyama (M)

Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH